Combination immune therapy shows promise against Hodgkin lymphoma
Tuesday, December 6, 2016 - 20:51
in Health & Medicine
The combination of two new drugs that harness the body’s immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to the results of an early-phase study.